glp-1 news updates november 2025 Who Gets the Shot? Access by State GLP-1 Pharmacy Pricing Update (Dec

doi: 10.1113/jphysiol.2006.119644

Monitor for any GI symptoms (rare at this dose)

While some patients experience diarrhea, others develop constipation, and many notice changes in bowel frequency or consistency

Given common questions of fact and law raised in complaints filed throughout the federal court system, all GLP-1 lawsuits have been centralized as part of a multidistrict litigation (MDL) in the Eastern District of Pennsylvania, where they are currently being overseen by U.S

25 Balance model The Centers for Medicare and Medicaid Services (CMS) also announced the Better Approaches to Lifestyle and Nutrition for Comprehensive Health (BALANCE) model with aims to increase access to selected GLP-1s in Medicaid and Medicare

The glucometabolic effects of GLP-1 have been reviewed extensively elsewhere [18] and are not the focus of the current review